These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15767616)

  • 1. Summaries for patients. Can a blood test help predict who is at risk for colorectal cancer?
    Ann Intern Med; 2005 Mar; 142(6):I79. PubMed ID: 15767616
    [No Abstract]   [Full Text] [Related]  

  • 2. C-reactive protein levels are not associated with increased risk for colorectal cancer in women.
    Zhang SM; Buring JE; Lee IM; Cook NR; Ridker PM
    Ann Intern Med; 2005 Mar; 142(6):425-32. PubMed ID: 15767620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein and risk for colorectal cancer.
    Mascitelli L; Pezzetta F
    Ann Intern Med; 2005 Oct; 143(7):544; author reply 544. PubMed ID: 16204172
    [No Abstract]   [Full Text] [Related]  

  • 4. C-reactive protein elevation and the risk of colorectal cancer.
    Saddler D; Greenwald B
    Gastroenterol Nurs; 2004; 27(5):246-7. PubMed ID: 15502522
    [No Abstract]   [Full Text] [Related]  

  • 5. Is C-reactive protein useful in prognostication for colorectal cancer? A systematic review.
    Pathak S; Nunes QM; Daniels IR; Smart NJ
    Colorectal Dis; 2014 Oct; 16(10):769-76. PubMed ID: 25039573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies.
    Tsilidis KK; Branchini C; Guallar E; Helzlsouer KJ; Erlinger TP; Platz EA
    Int J Cancer; 2008 Sep; 123(5):1133-40. PubMed ID: 18528865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is C-reactive protein a prognostic factor of colorectal cancer?
    Shiu YC; Lin JK; Huang CJ; Jiang JK; Wang LW; Huang HC; Yang SH
    Dis Colon Rectum; 2008 Apr; 51(4):443-9. PubMed ID: 18172726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No higher risk for colorectal cancer in atrophic gastritis-related hypergastrinemia.
    Lahner E; Sbrozzi-Vanni A; Vannella L; Corleto VD; Di Giulio E; Delle Fave G; Annibale B
    Dig Liver Dis; 2012 Sep; 44(9):793-7. PubMed ID: 22595617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupational asbestos exposure and risk of esophageal, gastric and colorectal cancer in the prospective Netherlands Cohort Study.
    Offermans NS; Vermeulen R; Burdorf A; Goldbohm RA; Keszei AP; Peters S; Kauppinen T; Kromhout H; van den Brandt PA
    Int J Cancer; 2014 Oct; 135(8):1970-7. PubMed ID: 24585528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative plasma fibrinogen, but not D-dimer might represent a prognostic factor in non-metastatic colorectal cancer: A prospective cohort study.
    Hong T; Shen D; Chen X; Wu X; Hua D
    Cancer Biomark; 2017; 19(1):103-111. PubMed ID: 28269756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute-phase proteins in colorectal cancer].
    Dumitraşcu D; Stanciu L; Radu D; Dejica D; Ban A; Ioniţă A; Petcovici M; Duca S; Cazacu M; Funaru G
    Med Interna; 1992; 44(2-4):41-6. PubMed ID: 1285361
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective study of serum C-reactive protein and colorectal cancer risk in men.
    Gunter MJ; Stolzenberg-Solomon R; Cross AJ; Leitzmann MF; Weinstein S; Wood RJ; Virtamo J; Taylor PR; Albanes D; Sinha R
    Cancer Res; 2006 Feb; 66(4):2483-7. PubMed ID: 16489056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summaries for patients. C-reactive protein and prediction of risk for cardiovascular disease in women.
    Ann Intern Med; 2006 Jul; 145(1):I19. PubMed ID: 16818922
    [No Abstract]   [Full Text] [Related]  

  • 14. Association Among Obesity, Metabolic Health, and the Risk for Colorectal Cancer in the General Population in Korea Using the National Health Insurance Service-National Sample Cohort.
    Shin CM; Han K; Lee DH; Choi YJ; Kim N; Park YS; Yoon H
    Dis Colon Rectum; 2017 Nov; 60(11):1192-1200. PubMed ID: 28991084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic criteria in colorectal carcinoma constructed by the combination of tumor-related and host-related factors.
    Nozoe T; Matono R; Ijichi H; Ohga T; Ezaki T
    Am J Surg; 2014 Jul; 208(1):119-23. PubMed ID: 24612685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Postoperative Systemic Inflammation Score Predicts Short- and Long-Term Outcomes in Patients Undergoing Surgery for Colorectal Cancer.
    Watt DG; McSorley ST; Park JH; Horgan PG; McMillan DC
    Ann Surg Oncol; 2017 Apr; 24(4):1100-1109. PubMed ID: 27822634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer.
    Yakabe T; Nakafusa Y; Sumi K; Miyoshi A; Kitajima Y; Sato S; Noshiro H; Miyazaki K
    Ann Surg Oncol; 2010 Sep; 17(9):2349-56. PubMed ID: 20217258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating mitochondrial stress 70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancer.
    Jubran R; Kocsis J; Garam N; Maláti É; Gombos T; Barabás L; Gráf L; Prohászka Z; Fishelson Z
    Int J Cancer; 2017 Dec; 141(11):2329-2335. PubMed ID: 28791678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.
    Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein and the risk of incident colorectal cancer.
    Erlinger TP; Platz EA; Rifai N; Helzlsouer KJ
    JAMA; 2004 Feb; 291(5):585-90. PubMed ID: 14762037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.